KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Common Equity (2016 - 2025)

Historic Common Equity for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Colgate Palmolive's Common Equity rose 4808.61% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 4808.61%. This contributed to the annual value of $544.0 million for FY2024, which is 4315.57% down from last year.
  • As of Q3 2025, Colgate Palmolive's Common Equity stood at $1.2 billion, which was up 4808.61% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Colgate Palmolive's Common Equity peaked at $24.4 billion during Q4 2021, and registered a low of -$25.1 billion during Q4 2022.
  • Over the past 5 years, Colgate Palmolive's median Common Equity value was $728.0 million (recorded in 2022), while the average stood at $616.7 million.
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 20319.51% in 2022, then surged by 11825.73% in 2025.
  • Over the past 5 years, Colgate Palmolive's Common Equity (Quarter) stood at $24.4 billion in 2021, then plummeted by 203.2% to -$25.1 billion in 2022, then soared by 103.81% to $957.0 million in 2023, then crashed by 43.16% to $544.0 million in 2024, then soared by 127.57% to $1.2 billion in 2025.
  • Its Common Equity stands at $1.2 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $733.0 million for Q1 2025.